Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.

@article{Tripsianis2014CoexpressionOI,
  title={Coexpression of IL-6 and TNF-$\alpha$: prognostic significance on breast cancer outcome.},
  author={Gregory Tripsianis and Evropi G Papadopoulou and Konstantinos Anagnostopoulos and Sotirios Botaitis and Michael Katotomichelakis and Konstantinos Romanidis and Emmanuel N Kontomanolis and Ioannis K. Tentes and Alexandros H. Kortsaris},
  journal={Neoplasma},
  year={2014},
  volume={61 2},
  pages={
          205-12
        }
}
Presented study was conducted to investigate the prognostic significance of the coexpression of serum interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) in breast cancer, by correlating their presence with clinicopathological characteristics indicative of tumor progression and the overall survival of breast cancer patients. One hundred twelve consecutive patients with primary breast cancer were prospectively included and evaluated. Serum concentrations of IL-6 and TNF-a were measured by… Expand
Prognostic significance of inflammatory factors expression by stroma from breast carcinomas.
TLDR
The combination of the expression of IL-1β, IL-6 and IL-10 may serve as promising biomarkers of MICs with prognostic significance, contributing to a better characterization of breast carcinomas microenvironment. Expand
Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
TLDR
Increased levels of IL-6 and IL-8 are associated with factors of worse prognosis in ovarian cancer, and additional studies are needed to confirm the role of cytokines as prognostic factors, in the definition of treatment, and in the development of future target therapies. Expand
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
TLDR
A rationale for a breast cancer treatment regime that simultaneously suppresses multiple targets, as these cytokines possess many overlapping functions that increase metastasis and worsen patient survival is provided. Expand
The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches
TLDR
The known molecular effects of TNF-α signaling in breast cancer cells are corroborated with the results from several preclinical and clinical trials, including T NF-α-related clinical observations, and a pro-tumorigenic role is revealed during breast cancer progression and metastasis. Expand
AVALIAÇÃO DE BIOMARCADORES INFLAMATÓRIOS MOLECULARES EM PACIENTES COM CÂNCER DE MAMA
TLDR
The data suggests no differences in the levels of MPs and inflammatory cytokines comparing breast cancer patients and healthy women, but breast cancer seems to have a more localized inflammatory response and induces a modulation of the immune system response. Expand
Significance of Interleukin-6 in Papillary Thyroid Carcinoma
TLDR
IL-6 has an important role in thyroid cancer progression and targeting IL-6 signalling can help in clinical management of thyroid carcinoma patients, according to this study. Expand
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
TLDR
It is suggested that NLR is a good prognostic marker for BC, and patients with a higher NLR have poorer prognoses, and future studies should perform more detailed investigations to decrease heterogeneity and determine the appropriate cut-off values for different races. Expand
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer.
TLDR
It seems that targeting IL-6 and/or its receptor in combination with other potent anticancer therapies may be a potent therapeutic approach for breast cancer therapy. Expand
Efficacy analysis of trastuzumab, carboplatin and docetaxel in HER-2-positive breast cancer patients.
TLDR
In conclusion, trastuzumab, carboplatin and docetaxel present high efficacy, safety, and 5-year DFS and OS in HER-2-positive breast cancer patients, and have good recovery effect on inflammation, immune response and oxidative stress. Expand
Tumor associated neutrophils promote the metastasis of pancreatic ductal adenocarcinoma
TLDR
The study indicated that neutrophils may increase the metastasis of PDAC by releasing a series of cell cytokines, such as TNF-α and TGF-β1. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Prognostic Value of Proinflammatory Cytokines in Breast Cancer
TLDR
The finding suggest that serum levels of IL-1α, IL-6 and TNF-α appears to be of some prognostic value in breast cancer. Expand
Serum Level of Interleukin 6 & Tumor Necrosis Factor in Iraqi Breast Cancer patients
  • 2012
Interleukin 6 (IL‐6) and tumor necrosis factor α (TNF‐α) may be used as a prognostic value in breast cancer .Serum levels of IL‐6 , TNF ‐ α were elevated significantly, among the 40 Expand
Significance of interleukin-6 (IL-6) in breast cancer (review)
TLDR
The role of IL-6 in in vitro experiments of breast tumor cells, in breast tumor tissues (BTs) and its potential as a prognostic indicator in breast cancer patients is reviewed and data are surprisingly unique showing IL- 6 to be a negative prognosticator in breast tumors patients. Expand
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
TLDR
Serum levels of IL-6 correlates well with the extent of tumor invasion, LN metastasis, distant metastasis and TNM staging thus enveloping all aspects of breast cancer. Expand
Plasma levels of IL-6 and TNF-a in patients with esophageal cancer
TLDR
The results show that IL-6 and TNF-a plasma levels may be utilized as tumor markers for the diagnosis of esophageal cancer, however, to definitely conclude this, needs further extensive studies. Expand
Oestrogen receptor negative breast cancers exhibit high cytokine content
TLDR
It is found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines – MCP-1, MIP-1β and IL-8 – were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours. Expand
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
TLDR
It is concluded that circulating IL‐6 is associated with worse survival in patients with metastatic breast cancer and is correlated with the extent of disease. Expand
Potential prognostic and therapeutic roles for cytokines in breast cancer (Review).
TLDR
The role of cytokines in the immune response against breast cancer and their potential as prognostic indicators and/or use in immune therapy are reviewed. Expand
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies.
BACKGROUND For optimum management of patients with cancer, accurate assessment of prognosis is essential. The primary determinant of outcome in malignancy is the formation of distant metastases.Expand
Cytokines in breast cancer.
TLDR
Two long-term pilot studies suggest that IL-2 and IFNbeta, when used appropriately can have a positive effect on clinical benefit and overall survival of patients with minimal residual disease after chemotherapy or with disseminated disease controlled by conventional endocrine therapy. Expand
...
1
2
3
4
5
...